The purpose of this study is to determine whether a clinical diagnosis of irritable bowel syndrome based on patient reported symptoms and a few blood tests is safe, and to determine whether a clinical diagnosis is as good for the patient and as economical for the society as a diagnosis based on exclusion of a number of organic diseases by performing a number of blood tests, fecal analyzes and a scopic examination of bowel. The purpose of the second part of the study is to determine which intestinal parasites the patients have in their bowel and whether these parasites are the cause of the disease.
Study Type
OBSERVATIONAL
Enrollment
149
Patient fulfill ROME III criteria No Alarmsignals Blood tests: FBC,CRP, ALAT, bilirubins, bas.phosphatases, Albumine, TSH, calcium, celiac screening, lactase gene test. 3 consecutive fecal samples for worm, ovaes and parasites Sigmoidoscopy with biopsy
Patient fulfill ROME III criteria No Alarm signals Blood tests: FBC, CRP.
Medical Departement, Koege Hospital
Køge, Denmark
health related quality of life measured by SF-36
Time frame: baseline and after 1 year
Symptoms measured by GSRS and GSRS-IBS
Time frame: baseline, every month for a year and after 1 year
sick days and reduced productivity measured by WPAI:IBS
Time frame: baseline, every month and after 1 year
differential diagnoses in both arms
Time frame: 1 year
Health related quality of life measured by IBS-QOL measurement
Time frame: baseline and after 1 year
The overall satisfaction with the diagnostic strategy
Time frame: after initial diagnostic work up and after 1 year
The use of resources in the health care system measured by the number of doctor visits, ambulatory visits, emergency room visits, hospitalizations and diagnostic tests over 1 year follow up.
Time frame: every month and after 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.